Active Site Polymerase Inhibitor Nucleotides (ASPINs) for Chronic Hepatitis B Infection

Time: 3:30 pm
day: Day Two


  • ASPINs target the HBV polymerase in a mechanistically unique way from nucleoside analogues
  • ASPINs have demonstrated preclinical and clinical sustained suppression of HBV viremia
  • ASPINs may be an integral component of curative regimens